CClinicalTrials.gg
TerminatedNCT00219505Updated Nov 24, 2017

Effect of Acupuncture on Symptoms of Diarrhea and Pain in IBS

An interventional study of acupuncture in Irritable Bowel Syndrome, sponsored by Penn State University. Terminated at 1 site in United States. Open to participants aged 18 Years to 90 Years. Per ClinicalTrials.gov, last updated 2017-11-24.

Sponsored by Penn State University · Not applicable, Interventional, and Treatment

Why this study was terminated
no eligible subjects identified during recruitment
Phase
Not applicable
Study type
Interventional
Enrollment
36
Allocation
Randomized
Ages
18 Years to 90 Years
Sex
All
01

Study summary

Acupuncture has been used for centuries in China in the treatment of diarrhea. Our hypothesis is that acupuncture is effective in the treatment of abdominal pain and diarrhea in patients with diarrhea-predominant IBS

Read the detailed description

Patients will complete a diary to determine if they qualify for the study. Patients will be randomized to receive either acupuncture or sham acupuncture (needle insertion 1 cm away from acupuncture site). Patients will be blinded to whether they are receiving acupuncture or sham acupuncture. The acupuncturist is blinded as to the patient response. The patients will undergo venupuncture to draw blood to determine sertotonin and beta-endorphin levels. They will receive treatment in 12 sessions over 4 weeks. They will maintain a diary during this time period to document level of pain and frequency of bowel movements. Blood will be drawn at week 2 and 4 and, 6 weeks after cessation of treatment, subjects will again record abdominal symptoms and frequency of bowel movements for 2 weeks. Blood will be drawn for hormone levels at 8 weeks after completion of study.

02

Conditions studied

  • Irritable Bowel Syndrome

Keywords

  • Diarrhea-predominant irritable bowel syndrome
  • Acupuncture
  • abdominal pain
03

In context

Irritable Bowel Syndrome

1,062 studies on the registry are indexed under Irritable Bowel Syndrome; 190 are open to participants now.

This study's enrollment of 36 is below the median of 71 across 853 interventional studies indexed under Irritable Bowel Syndrome.

Browse Irritable Bowel Syndrome studies →

Lead sponsor

Penn State University is the lead sponsor of 263 studies on the registry; 51 are open to participants now.

Of its 13 completed or terminated interventional studies of FDA-regulated products, 10 (77%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 90 Years
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • frequence of bowel movement of at least 3/day
  • global disease severity of at least 3

Exclusion criteria

Exclusion Criteria:

  • taking medications which will influence frequency of bowel movement
  • patient taking anticoagulants or suffering from coagulopathy
  • pregancy
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Factorial assignment
Masking
Single
Enrollment
36 participants

Interventions

  • Procedureacupuncture
06

What researchers measure

Primary outcomes

  1. Frequency of bowel movement

Secondary outcomes

  1. Abdominal pain

07

Study locations

1 site
  • Hershey Medical Center
    Hershey, Pennsylvania 17033, United States
08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Nov 24, 2017, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT00219505
Lead sponsor
Penn State University
Collaborators
American College of Gastroenterology
Responsible party
Sponsor
First posted
Sep 22, 2005
Start date
Aug 2001
Completion
Jan 2004
Last update
Nov 24, 2017

Study contacts

Ann Ouyangm, MD
principal investigator · Penn State College of Medicine and Penn State Milton S. Hershey Medical Center
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is terminated, as verified in Nov 2017. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion